Skip to content
OpenCapital
Get started

LENZ Therapeutics, Inc. LENZ Q3 2025 earnings

Reported November 5, 2025 · Before market open

Revenue$12.5MBeat by $9.5M
EPS-$0.59Beat by $0.08
Revenue estimate$3.0M
EPS estimate-$0.67

Next report

Jul 29, 2026 (Today)
Revenue estimate$2.4M
EPS estimate-$1.05

Versus estimates

Revenue

Q1 2026$1.9MBeat by $142.1KQ4 2025$1.6MMiss by $1.5M
Q3 2025$12.5MBeat by $9.5M
Q2 2025$5.0MBeat by $4.3M

Diluted EPS

Q1 2026-$1.32Miss by $0.22Q4 2025-$1.16Miss by $0.25
Q3 2025-$0.59Beat by $0.08
Q2 2025-$0.53Beat by $0.05Q1 2025-$0.53Beat by $0.02Q4 2024-$0.46Miss by $0.04

Ask the moment LENZ Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did LENZ Therapeutics, Inc. report Q3 2025 earnings?
LENZ Therapeutics, Inc. (LENZ) reported Q3 2025 earnings on November 5, 2025 before market open.
What were LENZ Therapeutics, Inc.'s Q3 2025 revenue and EPS?
LENZ Therapeutics, Inc. reported revenue of $12.5M and eps of $-0.59 for Q3 2025.
Did LENZ Therapeutics, Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $3.0M by $9.5M. EPS beat the consensus estimate of $-0.67 by $0.08.
How did LENZ Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 55.3% from $-0.38.
Where can I find LENZ Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001815776-25-000069) and the 10-Q periodic report (0001815776-25-000071) directly on SEC EDGAR. The filing index links above go to sec.gov.